Modified Perfusion for Neonatal Aortic Arch Reconstruction
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
Even though the lower part of the body does receive some blood supply during Cardiopulmonary Bypass(CPB) surgery, it may not be enough. As a result of this lowered blood supply, there are complications associated with CPB and clamping of the aorta. These include complications with the stomach, intestines and kidneys.
The hypotheses of this study are that increased lower body perfusion during aortic arch reconstruction will decrease intestinal ischemia and the incidence of necrotizing enterocolitis, improve renal function in the postoperative period, and shorten both intensive care unit and hospital length of stay.
The purpose of this research study is to provide the lower part of the body and its organs with possibly more blood supply with a modified form of cardiopulmonary bypass and see if this additional blood supply helps to decrease complications of the kidney, stomach and intestines.
| Condition | Intervention |
|---|---|
|
Aortic Arch Hypoplasia or Atresia |
Procedure: Modified Selective Cerebral Perfusion |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of a Modified Perfusion Strategy for Neonatal Aortic Arch Reconstruction: Does Perfusing the Lower Body During Arch Repair Help? |
- Intestinal Fatty Acid Binding Protein and C-reactive Protein [ Time Frame: Baseline and 0, 3, 12, and 24 hours after surgery ] [ Designated as safety issue: No ]
- iFAB Post-op [ Time Frame: Immediate postop ] [ Designated as safety issue: No ]intestinal fatty acid binding protein level immediately postop
- Cerebral and Lower Body Near Infra-red Spectroscopy Measures [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
| Enrollment: | 14 |
| Study Start Date: | June 2007 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Control
Arm 1 is the control arm. This arm will receive the standard cardiopulmonary bypass circuit.
|
|
|
Active Comparator: Experimental
This arm is the modified selective perfusion arm. This arm will receive the modified cardiopulmonary circuit.
|
Procedure: Modified Selective Cerebral Perfusion
Modified Selective perfusion is a cardiopulmonary bypass circuit that has been modified to allow blood flow to the lower body as well as the upper body while the surgery is being performed.
Other Name: Modified selective cerebral perfusion
|
Detailed Description:
As the aorta is repaired, the child has no circulation to the body or brain. While short periods of circulatory arrest were well tolerated, a modified technique called selective cerebral perfusion was developed to maintain blood flow to the brain during aortic repairs so as to allow for less hurried repairs with less concern over brain ischemia and injury.
Selective cerebral perfusion is designed to provide flow to the brain via the right carotid artery and collateral intracranial vessels while the aortic arch is isolated for repair. It is felt that collateral vessels also allow some perfusion of the lower body, but the adequacy of lower body perfusion during selective cerebral perfusion has not been well documented. While it is clear that some blood reaches the lower body, the incidence of renal and gastrointestinal complications following cardiac repairs involving aortic arch reconstructions remains significant.
The goal of this proposal is to evaluate a simple modification of the standard selective cerebral perfusion protocol designed to increase perfusion to the lower body during aortic arch reconstructions. Essentially all children who undergo aortic arch reconstruction at Egleston hospital have either a femoral or umbilical artery catheter in place for routine monitoring. During selective cerebral perfusion, the descending thoracic aorta is clamped, so the lower body arterial line is not a useful monitor at that point. We propose to connect a pressure line from the cardiopulmonary bypass circuit to the lower body arterial catheter, allowing for increased perfusion of the lower body through the femoral/umbilical arterial catheter during selective cerebral perfusion We will monitor simultaneous near infra-red spectroscopy of the brain, flank, and thigh to determine the adequacy of oxygen delivery to the brain, kidney, and lower body musculature during the procedure. Near infra-red spectroscopy provides a measure of the oxygenation of hemoglobin in arterial, capillary, and venous blood within the path of an infra-red sensor. Blood samples will be collected before skin incision, at the end of the procedure, and at 3, 12, and 24 hours after arrival to the intensive care unit. Intestinal fatty acid binding protein (i-FABP) and c-reactive protein (CRP) serum levels will be measured at each timepoint as markers of intestinal ischemia and generalized inflammation respectively. The incidence of documented or suspected necrotizing enterocolitis prior to hospital discharge and the time required to achieve full enteral feeds will be recorded. Renal function will be assayed by the maximal change from preoperative to postoperative serum creatinine, normalized urine output per 12 hour period following surgery, total diuretic dose per day, and daily creatinine clearance for the first 3 days after surgery.
Eligibility| Ages Eligible for Study: | up to 1 Year |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis including aortic coarctation, arch hypoplasia, or interrupted aortic arch which requires cardiopulmonary bypass for repair
- age less than 1 year
- parental consent for participation
Exclusion Criteria:
- prior aortic arch operations
- emergency operation
- operating surgeon decides that selective cerebral perfusion is not indicated
- Documented renal insufficiency (creatinine > 2.0) or evidence of bowel ischemia prior to surgery
Contacts and Locations| United States, Georgia | |
| Children's Healthcare of Atlanta | |
| Atlanta, Georgia, United States, 30322 | |
| Principal Investigator: | Paul Kirshbom, MD | Emory University |
More Information
Publications:
| Responsible Party: | Paul Kirshbom, MD, Children's Healthcare of Atlanta at Egleston |
| ClinicalTrials.gov Identifier: | NCT00490256 History of Changes |
| Other Study ID Numbers: | 00002654 |
| Study First Received: | June 20, 2007 |
| Results First Received: | July 8, 2011 |
| Last Updated: | July 8, 2011 |
| Health Authority: | United States: Food and Drug Administration United States: Institutional Review Board |
Keywords provided by Emory University:
|
Selective Cerebral Perfusion Renal Complications Gastrointestinal Complications Aortic Arch Reconstruction Modified Perfusion Cardiopulmonary Bypass Pediatrics |
Cardiac Defects intestinal ischemia necrotizing entercolitis Near Infra-red spectroscopy Creatinine C-reactive protein levels |
ClinicalTrials.gov processed this record on May 16, 2013